IL134395A - Compressed nitrogylycerin tablet and its method of manufacture - Google Patents

Compressed nitrogylycerin tablet and its method of manufacture

Info

Publication number
IL134395A
IL134395A IL13439598A IL13439598A IL134395A IL 134395 A IL134395 A IL 134395A IL 13439598 A IL13439598 A IL 13439598A IL 13439598 A IL13439598 A IL 13439598A IL 134395 A IL134395 A IL 134395A
Authority
IL
Israel
Prior art keywords
nitroglycerin
tablets
tablet
stable
direct compression
Prior art date
Application number
IL13439598A
Other languages
English (en)
Other versions
IL134395A0 (en
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL134395A0 publication Critical patent/IL134395A0/xx
Publication of IL134395A publication Critical patent/IL134395A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL13439598A 1997-10-03 1998-09-16 Compressed nitrogylycerin tablet and its method of manufacture IL134395A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6110597P 1997-10-03 1997-10-03
PCT/US1998/019356 WO1999017766A1 (en) 1997-10-03 1998-09-16 Compressed nitroglycerin tablet and its method of manufacture

Publications (2)

Publication Number Publication Date
IL134395A0 IL134395A0 (en) 2001-04-30
IL134395A true IL134395A (en) 2005-08-31

Family

ID=22033623

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13439598A IL134395A (en) 1997-10-03 1998-09-16 Compressed nitrogylycerin tablet and its method of manufacture

Country Status (16)

Country Link
US (1) US6500456B1 (xx)
EP (1) EP1019039B1 (xx)
JP (1) JP2001518500A (xx)
KR (1) KR100569763B1 (xx)
AT (1) ATE209911T1 (xx)
AU (1) AU759018B2 (xx)
BR (1) BR9812605B1 (xx)
CA (1) CA2299231C (xx)
DE (1) DE69802832T2 (xx)
DK (1) DK1019039T3 (xx)
ES (1) ES2169558T3 (xx)
IL (1) IL134395A (xx)
NZ (1) NZ502878A (xx)
PT (1) PT1019039E (xx)
TW (1) TWI228989B (xx)
WO (1) WO1999017766A1 (xx)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
CA2348452A1 (en) * 1998-10-27 2000-05-04 Biovail Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
US7815936B2 (en) 2001-10-30 2010-10-19 Evonik Degussa Gmbh Use of granular materials based on pyrogenically produced silicon dioxide in pharmaceutical compositions
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
US9358296B2 (en) 2003-02-24 2016-06-07 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US10172810B2 (en) 2003-02-24 2019-01-08 Pharmaceutical Productions, Inc. Transmucosal ketamine delivery composition
US9498454B2 (en) 2003-02-24 2016-11-22 Pharmaceutical Productions Inc. Transmucosal drug delivery system
US9254294B2 (en) 2003-02-24 2016-02-09 Pharmaceutical Productions Inc. Transmucosal hormone delivery system
EP2343045A3 (en) * 2003-02-24 2011-09-21 Pharmaceutical Productions Inc. Transmucosal drug delivery system
CA2530843A1 (en) * 2003-07-01 2005-01-20 Todd Maibach Film comprising therapeutic agents
US7999003B2 (en) * 2003-08-26 2011-08-16 Mannatech, Incorporated Antioxidant compositions and methods thereto
US20060134202A1 (en) * 2004-12-22 2006-06-22 Hack Jacob C Homeopathic sublingual dosage forms and methods thereof
US8252329B2 (en) 2007-01-05 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US9066847B2 (en) 2007-01-05 2015-06-30 Aceirx Pharmaceuticals, Inc. Storage and dispensing devices for administration of oral transmucosal dosage forms
US8865743B2 (en) 2006-01-06 2014-10-21 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US8202535B2 (en) 2006-01-06 2012-06-19 Acelrx Pharmaceuticals, Inc. Small-volume oral transmucosal dosage forms
US8753308B2 (en) 2006-01-06 2014-06-17 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
US8357114B2 (en) 2006-01-06 2013-01-22 Acelrx Pharmaceuticals, Inc. Drug dispensing device with flexible push rod
US8252328B2 (en) * 2006-01-06 2012-08-28 Acelrx Pharmaceuticals, Inc. Bioadhesive drug formulations for oral transmucosal delivery
US8535714B2 (en) 2006-01-06 2013-09-17 Acelrx Pharmaceuticals, Inc. Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
US9289583B2 (en) 2006-01-06 2016-03-22 Acelrx Pharmaceuticals, Inc. Methods for administering small volume oral transmucosal dosage forms using a dispensing device
WO2008098195A2 (en) * 2007-02-09 2008-08-14 Todd Maibach Film comprising nitroglycerin
US20090004254A1 (en) * 2007-06-19 2009-01-01 Todd Maibach Film comprising active drugs
US20090048237A1 (en) * 2007-08-07 2009-02-19 Acelrx Pharmaceuticals, Inc. Compositions and methods for procedural sedation and analgesia using oral transmucosal dosage forms
US8945592B2 (en) * 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
US20110091544A1 (en) * 2009-10-16 2011-04-21 Acelrx Pharmaceuticals, Inc. Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
AU2011287948B2 (en) 2010-08-03 2014-11-06 G. Pohl-Boskamp Gmbh & Co. Kg Use of glyceryl trinitrate for treating traumatic edema
EP2678000B1 (en) 2011-02-25 2018-03-07 G. Pohl-Boskamp GmbH & Co. KG Stabilized granules containing glyceryl trinitrate
US9248099B2 (en) 2012-05-31 2016-02-02 Desmoid Aktiengesellschaft Use of stabilized granules containing glyceryl trinitrate for arteriogenesis
EP2668948A1 (en) * 2012-05-31 2013-12-04 G. Pohl-Boskamp GmbH & Co. KG Use of stabilized granules containing glyceryl trinitrate for arteriogenesis
HUE033092T2 (hu) 2012-05-31 2017-11-28 G Pohl-Boskamp Gmbh & Co Kg Arteriogenezis indukálása nitroglicerinnel mint nitrogén-oxid donorral
CN104602693A (zh) * 2012-08-31 2015-05-06 安斯泰来制药株式会社 口服给药用药物组合物
ES2821528T3 (es) 2012-11-14 2021-04-26 Grace W R & Co Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
US20140303227A1 (en) * 2013-03-14 2014-10-09 Pharmaceutical Productions Inc. Transmucosal hormone delivery system
EP2878310B1 (en) 2013-11-29 2017-01-11 G. Pohl-Boskamp GmbH & Co. KG Sprayable aqueous composition comprising glyceryl trinitrate
IL276030B (en) * 2014-02-07 2022-09-01 Sentar Pharmaceuticals Inc Non-toxic systems, from natural materials, for administering medicine under the tongue
CN113679682A (zh) * 2020-05-19 2021-11-23 珠海润都制药股份有限公司 一种硝酸甘油舌下片及其制备方法
CN114469881A (zh) * 2022-03-14 2022-05-13 河北坤安药业有限公司 一种硝酸甘油片及其制备方法
CN115154431B (zh) * 2022-07-21 2024-03-12 南京卓康医药科技有限公司 一种硝酸甘油片剂及其制备方法
CN117653610B (zh) * 2023-09-28 2024-07-05 海南卓科制药有限公司 一种硝酸甘油片及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2357503A1 (de) * 1973-11-17 1975-05-28 Cassella Farbwerke Mainkur Ag Verfahren zur herstellung von festen carbocromen-hydrochlorid enthaltenden praeparaten
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
WO1996036330A2 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Compositions containing fatty acids for improving digestion and absorption in the small intestine
US5874418A (en) * 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use

Also Published As

Publication number Publication date
NZ502878A (en) 2002-03-01
DK1019039T3 (da) 2002-03-25
TWI228989B (en) 2005-03-11
KR20010030839A (ko) 2001-04-16
AU759018B2 (en) 2003-04-03
IL134395A0 (en) 2001-04-30
EP1019039B1 (en) 2001-12-05
PT1019039E (pt) 2002-04-29
DE69802832D1 (de) 2002-01-17
BR9812605B1 (pt) 2009-01-13
EP1019039A1 (en) 2000-07-19
CA2299231A1 (en) 1999-04-15
WO1999017766A1 (en) 1999-04-15
US6500456B1 (en) 2002-12-31
AU9489398A (en) 1999-04-27
KR100569763B1 (ko) 2006-04-11
CA2299231C (en) 2003-03-18
BR9812605A (pt) 2000-08-01
JP2001518500A (ja) 2001-10-16
ES2169558T3 (es) 2002-07-01
ATE209911T1 (de) 2001-12-15
DE69802832T2 (de) 2002-06-20

Similar Documents

Publication Publication Date Title
IL134395A (en) Compressed nitrogylycerin tablet and its method of manufacture
KR900012606A (ko) 이중 정제
DK0501985T3 (da) Uovertrukket farmaceutisk reaktionstablet
NZ336789A (en) Use of methacrylic acid copolymer type C in the manufacture of tablets
EA199700110A1 (ru) Композиция с высоким содержанием ацетаминофена для прямого прессования
KR880012213A (ko) 이부프로펜 서방형 매트릭스 및 이의 제조방법
IL114984A (en) Pharmaceutical composition useful for making an oral extended release gepirone dosage form
IS7208A (is) Snöggbráðnandi lyfjagjafarform til inntöku um munn
MY120570A (en) Pharmaceutical preparation containing levothyroxine sodium
KR900004326A (ko) 디히드로에르고톡신 및 그의 산 부가염의 분산성 정제
ATE441410T1 (de) Fenofibrattabletten
EP0235363A3 (en) Sustained release tablets of theophylline
KR910011241A (ko) 정제로 직접 압착 가능한 약제학적 분말 조성물을 제조하기 위한 분무 건조법
GB9914936D0 (en) Directly compressible starch as enhancer of properties of excipients when used as binder and disintegrant for compression tablets
US5874107A (en) Sustained release tablet containing diclofenac-Na and methylhydroxypropyl-cellulose as a sustained release agent
KR100690311B1 (ko) 새로운 제약 조성물 및 그것의 제조방법
HU9602470D0 (en) Tablets containing captopril and process for producing them
US6322812B1 (en) Pharmaceutical forms for the oral administration of mesna
US20020183308A1 (en) Benazepril Hydrochloride tablet formulations
KR840001829A (ko) 새로운 이펜프로딜을 함유하는 정제의 제조방법
JP2004250398A (ja) 安定化したマレイン酸エナラプリルを含有する医薬用組成物
BR9813873A (pt) Base efervescente
YU28404A (sh) Brzo topljiva formulacija za oralno doziranje
UA42341A (uk) Тверда лікарська форма на основі малеату еналапрілу
JP2003119134A (ja) シンバスタチン含有錠剤

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees